U.S. Markets closed

Biohaven Pharmaceutical Holding Co Ltd (BHVN) CEO Vlad Coric Sold $5 million of Shares

- By insider

CEO of Biohaven Pharmaceutical Holding Co Ltd (BHVN) Vlad Coric sold 100,000 shares of BHVN on 03/14/2019 at an average price of $50.09 a share. The total sale was $5 million.

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders. Biohaven Pharmaceutical Holding Co Ltd has a market cap of $2.22 billion; its shares were traded at around $50.10 .


CEO Recent Trades:

  • CEO Vlad Coric sold 100,000 shares of BHVN stock on 03/14/2019 at the average price of $50.09. The price of the stock has increased by 0.02% since.

Directors and Officers Recent Trades:

  • Chief Commercial Officer John Tilton sold 10,000 shares of BHVN stock on 03/12/2019 at the average price of $50.11. The price of the stock has decreased by 0.02% since.
  • Director Declan Doogan sold 101,024 shares of BHVN stock on 03/01/2019 at the average price of $46.26. The price of the stock has increased by 8.3% since.
  • Director Julia P Gregory sold 12,000 shares of BHVN stock on 02/21/2019 at the average price of $43.56. The price of the stock has increased by 15.01% since.
  • Director Declan Doogan sold 2,078 shares of BHVN stock on 02/19/2019 at the average price of $45.48. The price of the stock has increased by 10.16% since.
  • Director Declan Doogan sold 40,000 shares of BHVN stock on 02/13/2019 at the average price of $44.31. The price of the stock has increased by 13.07% since.

For the complete insider trading history of BHVN, click here

.This article first appeared on GuruFocus.